link
Bookmarks
Corpus Callosum Mass
Karen L. Salzman, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe

DIFFERENTIAL DIAGNOSIS

    ESSENTIAL INFORMATION

    • Helpful Clues for Common Diagnoses

      • Helpful Clues for Less Common Diagnoses

        • Helpful Clues for Rare Diagnoses

          • Alternative Differential Approaches

            Selected References

            1. Dibble EH et al: Toxoplasmosis versus lymphoma: cerebral lesion characterization using DSC-MRI revisited. Clin Neurol Neurosurg. 152:84-89, 2017
            2. Godi C et al: High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients. Eur Radiol. ePub, 2017
            3. Igra MS et al: Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications. Br J Radiol. 20160721, 2017
            4. Lin X et al: Diagnostic accuracy of T1-weighted dynamic contrast-enhanced-MRI and DWI-ADC for differentiation of glioblastoma and primary CNS lymphoma. AJNR Am J Neuroradiol. 38(3):485-491, 2017
            5. Starkey J et al: Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics. 37(2):562-576, 2017
            6. Hodel J et al: Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab: diagnostic precision with MR imaging. Radiology. 278(3):863-72, 2016
            7. Wijburg MT et al: MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J Neurol Neurosurg Psychiatry. 87(10):1138-45, 2016
            8. Jordan JT et al: Magnetic resonance imaging observations in primary central nervous system lymphoma. JAMA Neurol. 71(7):918-9, 2014
            9. Garcia-Monco JC et al: Isolated and reversible lesions of the corpus callosum: a distinct entity. J Neuroimaging. 20(1):1-2, 2010
            Related Anatomy
            Loading...
            Related Differential Diagnoses
            Loading...
            References
            Tables

            Tables

            DIFFERENTIAL DIAGNOSIS

              ESSENTIAL INFORMATION

              • Helpful Clues for Common Diagnoses

                • Helpful Clues for Less Common Diagnoses

                  • Helpful Clues for Rare Diagnoses

                    • Alternative Differential Approaches

                      Selected References

                      1. Dibble EH et al: Toxoplasmosis versus lymphoma: cerebral lesion characterization using DSC-MRI revisited. Clin Neurol Neurosurg. 152:84-89, 2017
                      2. Godi C et al: High b-value diffusion-weighted imaging in progressive multifocal leukoencephalopathy in HIV patients. Eur Radiol. ePub, 2017
                      3. Igra MS et al: Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications. Br J Radiol. 20160721, 2017
                      4. Lin X et al: Diagnostic accuracy of T1-weighted dynamic contrast-enhanced-MRI and DWI-ADC for differentiation of glioblastoma and primary CNS lymphoma. AJNR Am J Neuroradiol. 38(3):485-491, 2017
                      5. Starkey J et al: Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics. 37(2):562-576, 2017
                      6. Hodel J et al: Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab: diagnostic precision with MR imaging. Radiology. 278(3):863-72, 2016
                      7. Wijburg MT et al: MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J Neurol Neurosurg Psychiatry. 87(10):1138-45, 2016
                      8. Jordan JT et al: Magnetic resonance imaging observations in primary central nervous system lymphoma. JAMA Neurol. 71(7):918-9, 2014
                      9. Garcia-Monco JC et al: Isolated and reversible lesions of the corpus callosum: a distinct entity. J Neuroimaging. 20(1):1-2, 2010